The trademark application WAINUA was filed by AstraZeneca AB, a corporation established under the laws of the Kingdom of Sweden (the "Applicant"). The application was published for oppositions on July 16, 2023, and it was registered by office on October 23, 2023 without any oppositions.
It was designated 'Basic Application' for International Application 1763135 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).